A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro.
暂无分享,去创建一个
Maoquan Chu | Zheng-Ming Huang | Qing-Sheng Wu | Zheng-ming Huang | Wen Hu | Qingsheng Wu | Ping Chen | M. Chu | Yaping Ding | Wen Hu | Ping Chen | Ya-Ping Ding
[1] H. Sperling,et al. Phase II trial of titanocene dichloride in advanced renal-cell carcinoma , 1998, Cancer Chemotherapy and Pharmacology.
[2] Robert Langer,et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. , 2007, Biomaterials.
[3] E. Monti,et al. Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent. , 2005, Journal of inorganic biochemistry.
[4] N. Kröger,et al. Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer , 2000, Oncology Research and Treatment.
[5] P. Supaphol,et al. Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] P. Sadler,et al. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride. , 2000, Biochemistry.
[7] Kwangsok Kim,et al. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[8] F. Caruso,et al. Antitumor titanium compounds. , 2003, Mini reviews in medicinal chemistry.
[9] K. Zhu,et al. Preparation, characterization and nasal delivery of alpha-cobrotoxin-loaded poly(lactide-co-glycolide)/polyanhydride microspheres. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[10] H. Lee,et al. BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro. , 2003, International journal of pharmaceutics.
[11] P. Köpf-Maier,et al. Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract , 2004, Cancer Chemotherapy and Pharmacology.
[12] Shaobing Zhou,et al. Release pattern and structural integrity of lysozyme encapsulated in core-sheath structured poly(DL-lactide) ultrafine fibers prepared by emulsion electrospinning. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] Xin Wang,et al. BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[14] N. Bölgen,et al. Electrospun matrices made of poly(alpha-hydroxy acids) for medical use. , 2007, Nanomedicine.
[15] Wolfgang J Parak,et al. Multifunctionalized polymer microcapsules: novel tools for biological and pharmacological applications. , 2007, Small.
[16] M. Shive,et al. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[17] J. San Román,et al. Preparation and in vitro release studies of ibuprofen-loaded films and microspheres made from graft copolymers of poly(L-lactic acid) on acrylic backbones. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[18] Chi-Hwa Wang,et al. Electrospun Micro- and Nanofibers for Sustained Delivery of Paclitaxel to Treat C6 Glioma in Vitro , 2006, Pharmaceutical Research.
[19] Y. Mizushima,et al. Drug-incorporating calcium carbonate nanoparticles for a new delivery system. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[20] W. Gallagher,et al. Novel titanocene anti-cancer drugs derived from fulvenes and titanium dichloride , 2004 .
[21] John Layman,et al. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[22] L. Marks,et al. Local recurrence after surgery for early stage lung cancer , 2009, Cancer.
[23] F. Caruso,et al. Antitumor titanium compounds and related metallocenes. , 2004, Metal ions in biological systems.
[24] P. Köpf-Maier,et al. Tumor inhibition by titanocene complexes: Influence upon two xenografted human lung carcinomas , 2004, Journal of Cancer Research and Clinical Oncology.
[25] M. Harding,et al. Antitumour metallocenes: structure-activity studies and interactions with biomolecules. , 2000, Current medicinal chemistry.
[26] P. Sadler,et al. Metals in Medicine. , 1999, Angewandte Chemie.
[27] You Han Bae,et al. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[28] Seung Jin Lee,et al. Porous poly(l-lactide) membranes for guided tissue regeneration and controlled drug delivery: membrane fabrication and characterization , 1997 .
[29] H. Köpf,et al. Titanocene dichloride--the first metallocene with cancerostatic activity. , 1979, Angewandte Chemie.
[30] Jae-Do Nam,et al. Electrospun dual-porosity structure and biodegradation morphology of Montmorillonite reinforced PLLA nanocomposite scaffolds. , 2005, Biomaterials.
[31] Moncy V. Jose,et al. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering. , 2009, Acta biomaterialia.
[32] E. Thiel,et al. Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] Lixin Yang,et al. Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[34] K. Edwards,et al. Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[35] A. El-Aneed,et al. An overview of current delivery systems in cancer gene therapy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[36] T. Chung,et al. A method using biodegradable polylactides/polyethylene glycol for drug release with reduced initial burst. , 1999, International journal of pharmaceutics.
[37] P. Schwartz,et al. Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] M. Yamashita,et al. Very long-term outcomes of video-assisted thoracoscopic surgery for lung cancer , 2008, Surgical Endoscopy.